Abstract: Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.
Type:
Grant
Filed:
April 28, 2020
Date of Patent:
February 13, 2024
Assignee:
Temple University-Of The Commonwealth System Higher Education
Inventors:
Daniel J. Canney, Benjamin E. Blass, Rong Gao, Magid Abou-Gharbia